P2X7 inhibition (using silencing RNA) could prevent the formation of the NLRP3 inflammasome, limit infarct size and cardiac enlargement in AMI, and alleviate VR on the 7th day, which was characterized by slight ventricular dilatation and dysfunction [43]. Here, P2RX7 is linked to Ventriculomegaly.